Sa1716 DIAGNOSTIC CLASSIFICATION SYSTEMS FOR DISORDERS OF GUT-BRAIN INTERACTION SHOULD INCLUDE PSYCHOLOGICAL SYMPTOMS Read More →
Sa1697 GUT PERMEABILITY AND ITS ROLE IN PARKINSON'S DISEASE: PRELIMINARY RESULTS FROM A PILOT STUDY Read More →
Sa1696 EVIDENCE FOR BRAIN-TO-GUT CROSS TALK IN GENERAL PRACTICE PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE Read More →
Sa1695 DISORDERS OF GUT BRAIN INTERACTION, BUT NOT INFLAMMATORY BOWEL DISEASE ARE ASSOCIATED WITH TREATMENT OF PSYCHIATRIC DISRORDERS, A NORTHERN FINLAND BIRTH COHORT STUDY Read More →
498 THE GUT MICROBIOME REGULATES THE CLINICAL EFFICACY OF SULFASALAZINE THERAPY FOR IBD-ASSOCIATED SPONDYLOARTHRITIS Read More →
309 THE BASELINE GUT MICROBIOME OFFERS INSIGHTS INTO PREDICTING AND UNDERSTANDING THE HETEROGENEOUS NATURE OF LONG COVID Read More →
Sa1851 THE EFFECT OF DYSBIOTIC GUT MICROBIOTA IN FAMILIES WITH PEDIATRIC IBD ON INTESTINAL INFLAMMATION IN HUMANIZED GNOTOBIOTIC TL1A TRANSGENIC MICE Read More →
Sa1739 SURVEY OF CLINICIANS TREATING IRRITABLE BOWEL SYNDROME (IBS) WITH COGNITIVE BEHAVIORAL THERAPY AND/OR GUT-DIRECTED HYPNOSIS Read More →
Sa1734 NEGATIVE TRAINEE AND GASTROENTEROLOGIST ATTITUDES TOWARDS DISORDERS OF GUT-BRAIN INTERACTION ARE INITIATED AND PROPAGATED EARLY IN MEDICAL EDUCATION Read More →
Sa1779 USEFULNESS OF SERUM LRG AS A BIOMARKER FOR EVALUATING WHOLE COLONIC INFLAMMATION OF ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE STUDY BY THE OSAKA GUT FORUM Read More →
Sa1775 EPITHELIAL NEUTROPHIL LOCALIZATION AND CLAUDIN-2 IMMUNOHISTOCHEMICAL “LEAKY GUT” EXPRESSION ARE INNOVATIVE PREDICTORS OF OUTCOMES IN UC PATIENTS IN ENDOSCOPIC REMISSION Read More →
Su1929 METABOLIC PROFILES OF DRA-KO MICE: NOVEL INSIGHTS INTO THE INCREASED SUSCEPTIBILITY TO GUT INFLAMMATION Read More →
783 GUT TRANSIT TIME IS ASSOCIATED WITH MUCOSAL HOMEOSTASIS AND HOST-MICROBE CO-METABOLISM IN IBS Read More →
725 QUORUM QUENCHING DECREASES METASTATIC RATE WITHOUT AFFECTING GUT MICROBIOME COMPOSITION IN A COLORECTAL CANCER MODEL Read More →
